In a double-blind, randomised controlled trial, we studied 40 patients who received one oj jour intra-articular injections at the end oj arthroscopic surgery. Each group contained ten patients. The patients in Group 1 received normal saline 25 ml; those in Group 2 received bupivacaine 0.25% 25 ml; those in Group 3 received morphine 5 mg in normal saline 25 ml; and those in Group 4 received a combination oj bupivacaine 0.5% 12.5 ml and 5 mg oj morphine made up to 25 ml with normal saline to produce the same bupivacaine concentration as Group 2. At the time the patient awoke, and 30min, 1hr, 1hr 30min, 2hr, 4hr, 8hr, 12hr, and 24hr postoperatively, pain was assessed using a visual analogue scale. The need jor supplementary analgesic agents in the jirst 24 hours was recorded.
Arthroscopic meniscectomy of the knee-joint is a procedure frequently carried out on a day-case basis and may be associated with significant postoperative pain. The provision of localised analgesia of long duration with minimal side-effects would be ideal in this group of patients.
Intra-articular bupivacaine has proven efficacy as an analgesic agent following knee arthroscopy. [1] [2] [3] Interest has developed recently in the use of opioids to mediate antinociceptive effects in the peripheral nervous system. 4 Intra-articular morphine has been shown to have analgesic efficacy at local level following knee arthroscopy. 5 This study was conducted to assess the relative efficacy of intra-articular morphine, intra-articular bupivacaine and a combination of both compared with a saline control group. 
METHODS
Following Institutional Ethical Committee approval, forty ASA I patients who presented for elective knee arthroscopy and who required meniscectomy were studied.
Informed consent was received from all patients who were then randomised into four groups as follows:
Group I-normal saline 25 ml Group 2-bupivacaine 0.2511,70 25 ml Group 3-morphine 5 mg in normal saline 25 ml Group 4-bupivacaine 0.5% 12.5 ml and morphine 5 mg made up to a volume of 25 ml with normal saline. Only patients having therapeutic meniscectomy were included in the study.
Prior to premedication all patients were instructed in the use of the visual analogue scale to record pain.·'? All were premedicated with 0.15 mg/kg of diazepam orally two hours preoperatively.
A standardised general anaesthetic protocol was followed. Anaesthesia was induced with a sleep dose of propofol and maintained with isoflurane in nitrous oxide and oxygen. Patients breathed spontaneously through a laryngeal mask airway. No other analgesia was administered pre-or intraoperatively. At the conclusion of surgery the selected agent was injected intra-articularly. The thigh tourniquet remained inflated for ten minutes following injection.
Following emergence from anaesthesia all patients were assessed by a trained observer, blinded to the nature of the agent received by the patient. Assessment occurred at predetermined intervals, immediately the patient awoke, 30min, Ihr, Ihr 30min, 2hr, 4hr, 8hr, 12hr, and 24 hours postoperatively. Patients rated their pain from zero to ten on the visual analogue scale. Those patients with pain scores greater than 6 in the recovery room were treated with intravenous pethidine 25 mg repeated at five-minute intervals until the pain score was less than 6. A pain score of 6 was chosen as the cut-off point for pethidine administration on the basis that it was necessary to standardise analgesic policy to enable comparison of analgesic requirements postoperatively. The score of 6 was chosen in the belief gained from prior experience, that this degree of pai~ can be controlled with NSAID rather than systemic opioid. For those patients with pain scores less than 6, supplementary analgesia was provided with oral mefenamic acid 250 mg administered when requested. The total quantity of analgesia administered over the first 24 hours postoperatively was recorded.
Results were expressed as mean (± standard deviation). Analysis of variance was used to assess statistical significance between pain scores and Student's (-test to assess differences in supplementary analgesic requirements between the groups. A P value of less than 0.05 was considered significant.
RESULTS
There were no significant differences in the demographic characteristics and tourniquet time of the patients in the four groups ( Table 1) .
All pain scores were significantly lower in Groups 2, 3 and 4 compared to control Group 1 with the exception of Group 2 (bupivacaine alone) at 24 hours (Figure 1 ). Comparison of pain scores between Group 2 (bupivacaine alone) and Group 3 (morphine alone) demonstrated a significantly lower pain score for the local anaesthetic group for the first 90 minutes postoperatively. There was no significant difference between the two groups at two hours postoperatively. At 4, 8, 12 and 24 hours postoperatively, Group 3 had significantly lower pain scores than Group 2. Group 4 (combined bupivacaine and morphine) had the lowest pain score profile compared to all other groups (Figure 1) .
The need for supplemental analgesic agents was significantly lower (P < 0.05) in Groups 2, 3 and 4 compared with Group I. Pethidine was required for five patients in Group 1 but for no patient in Groups 2, 3 and 4. There was no significant difference in supplemental analgesic requirements between Groups 2, 3 and 4 ( Table 2 ). 
DISCUSSION
Bupivacaine provides excellent early onset analgesia. Its duration of action has been reported to be 2 to 4 hours. 1, 8 Other authors have suggested a longer duration of action. 3 Our experience in this study suggests a significant analgesic effect for up to 12 hours postoperatively compared with the saline control group.
Plasma bupivacaine levels measured after arthroscopy have been shown to peak well below those required to produce toxic reactions;I,3 however, although bupivacaine itself seems to be well tolerated, the solution in which it is prepared is transiently inhibitory of the uptake of sulphates in articular cartilage ..
Recent evidence indicates that opioids can produce pronounced antinociceptive effects by interacting with local opioid receptors in peripheral inflamed tissue",lo Subsequent work has demonstrated that intra-articular morphine can produce significant analgesia devoid of side-effects reaching an apparent maximum effect between three and six hours after injection.' The onset of peak analgesia with intra-articular morphine in this study occurred between one and two hours postoperatively. This finding may relate to two differences in technique in this study compared with that of Stein et al. ' Firstly we used a morphine concentration of 200 mcg/ml in 25 ml compared to 25 mcg/ml in 40 ml. In addition we maintained tourniquet inflation for 10 minutes following intra-articular injection, which might allow for increased local tissue binding of the drug within the knee-joint and possibly increase the effectiveness of the agent in providing analgesia.
Pain scores in the bupivacaine group were significantly lower than the morphine group for the first 90 minutes postoperatively. However, pain scores in the morphine group became significantly lower than the Anaesthesia and Intensive Care, Vol. 21, No. 2, April, 1993 bupivacaine group at 4, 8, 12 and 24 hours. This would suggest that a combination of both agents should complement one another, bupivacaine providing immediate onset of action and morphine a longer duration of action. This resulted in Group 4 (combined morphine and bupivacaine) providing the most effective analgesia compared with that achieved by either drug independently.
